INTS vs NDSN
Intensity Therapeutics, Inc. Common stock (INTS) versus Nordson Corporation (NDSN) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Nordson Corporation (NDSN) is a specialty industrial machinery company listed on NASDAQ.
INTS does not have a complete income-statement cache yet.
Latest reported NDSN revenue for 2024-10-31 was $2.69B. Net income was $467.3M. Revenue was up 2.3% from 2023-10-31 to 2024-10-31. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
INTS currently screens at market cap $7.7M. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
Not investment advice. Open the INTS and NDSN stock pages for the full models.
Not investment advice.